SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending due to its pivot towards quantum computing for cryptocurrency applications, generating excitement around energy-efficient blockchain $BTC infrastructure. The community is discussing the potential of LightSolver's laser-based processing units and comparing QCLS to other quantum and crypto-related stocks like $RGTI and $QBTS. Traders are monitoring the stock's threshold list status and anticipating news regarding partnerships and potential contract announcements.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to increased investor interest in quantum computing and recent purchase orders for its quantum systems. The community is discussing the company's potential for growth and comparing it to other quantum computing stocks like IONQ and QBTS. Despite some concerns about valuation, positive sentiment and bullish momentum are driving conversation.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending as the quantum computing sector gains momentum, with community members discussing the company's potential and recent developments like Comcast's partnership and police response time improvements. Discussions revolve around the company's technology, potential acquisitions, and government contracts, with some comparing it to the dot-com bubble while others see tangible value in AI integration. Despite mixed sentiment, bullish investors are anticipating a squeeze and see long-term potential, while bears express concerns about valuation and revenue.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending as retail traders discuss a potential short squeeze, citing its collaboration with NVIDIA and government interest in quantum computing. Some traders point to the stock's high valuation and cash burn rate, while others highlight potential catalysts like government contracts and long-term growth in the sector. The community is actively debating dilution concerns and the validity of technical analysis on this stock.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending following news of a strategic partnership with Perplexity, an AI search engine, leading to overnight gains. The community is actively discussing the potential impacts of AI integration on content discovery and Rumble's future growth. Some traders are also pointing to high short interest as a potential catalyst for a short squeeze.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors discuss the implications of the upcoming warrant distribution and its potential impact on the stock price, with many anticipating volatility and a possible short squeeze. Community members are debating strategies around buying, holding, and exercising warrants, while others express frustration with the company's management and perceived market manipulation. Amidst the mixed sentiment, the conversation is lively with speculation about potential catalysts and the stock's long-term prospects within the broader meme stock landscape.

A multi-agent AI platform dissecting human nature’s first principles through iterative survival challenges and data-driven insights. Core dev has access to one of the founding partners of Two Sigma Ventures - the VC company of one of the biggest hedge funds in the world. Plans to raise seed round and scale after building organic foundation. Project devs are from academia space and are trying to bridge the gap between crypto and academia.

CortexZero

CortexZero is gaining attention, with community members highlighting its potential for a breakout. Conversations focus on strong buying activity and the possibility of significant upward movement. Some users are pointing to the token's chart and liquidity as indicators of a potential rally.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining attention, with community members sharing links to dex screener and the project's website. There is discussion around a token burn and the coin's association with weed culture. Some users are comparing it to Bitcoin and highlighting its potential within the broader cannabis industry.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending as traders discuss its potential in the drone and IoT space, especially regarding defense applications and contracts. Community members are pointing to the company's recent moves, like partnerships and investments, as signs of growth. The stock is gaining attention due to increasing drone-related news and speculation around upcoming earnings and potential catalysts.

Aster is a next-generation decentralized exchange offering both Perpetual and Spot trading, designed as a one-stop onchain venue for global crypto traders. It features MEV-free, one-click execution in Simple Mode. Pro Mode adds 24/7 stock perpetuals, Hidden Orders, and grid trading, available across BNB Chain, Ethereum, Solana, and Arbitrum.  Its unique edge lies in the ability to offer liquid-staking tokens (asBNB) or yield-generating stablecoins (USDF) as collateral, unlocking unparalleled capital efficiency. Powered by Aster Chain, a high-performance and privacy-focused L1, and backed by YZi Labs, Aster is building the future of DeFi: fast, flexible, and community-first.  At the heart of this ecosystem is the $ASTER token, a core asset that decentralizes governance, drives growth, rewards participation, and supports long-term sustainability.

ASTERION

ASTERION ($ASTER) is trending amid discussions about potential Binance listings and CZ's involvement, with some traders speculating about market manipulation and shorting opportunities. The community is actively debating price movements, airdrops, and whether ASTER can mirror the success of other perp DEXs, while also mentioning potential links to SAPIEN AI. Recent price volatility is fueling both bullish and bearish sentiments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wedbush Initiates a Buy Rating on Aprea Therapeutics (APRE)

In a report released today, Robert Driscoll from Wedbush initiated coverage with a Buy rating on Aprea Therapeutics (APRE Research Report) and a...

Analysts Are Bullish on These Healthcare Stocks: Aprea Therapeutics (APRE), TScan Therapeutics (TCRX)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aprea Therapeutics (APRE Research Report) and TScan Therapeutics...

Alltrna Announces Updates to Its Board of Directors

Alltrna Announces Updates to Its Board of Directors Alltrna Announces Updates to Its Board of Directors PR Newswire CAMBRIDGE, Mass., July 17, 2024 Chris Schade appointed as Board ChairpersonLynne...

Aprea Therapeutics files to sell 4.39M shares of common stock for holders

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Wedbush Boosts Aprea Therapeutics (NASDAQ:APRE) Price Target to $11.00

Aprea Therapeutics (NASDAQ:APRE - Free Report) had its target price lifted by Wedbush from $9.00 to $11.00 in a research report sent to investors on Wednesday, Benzinga reports. Wedbush currently has...

Brokers Set Expectations for Aprea Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:APRE)

Aprea Therapeutics, Inc. (NASDAQ:APRE  Free Report)  Equities researchers at Wedbush reduced their Q1 2024 EPS estimates for shares of Aprea Therapeutics in a research report issued on...

Buy Rating Affirmed: Aprea Therapeutics Poised for Growth with Strong Pipeline Momentum into 2024

Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on Aprea Therapeutics (APRE Research Report), with a price target of $20.00...

Aprea Therapeutics: Q4 Earnings Insights

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

First-in-class macrocyclic ATR inhibitor, ATRN-119, on track to complete dose escalation and potentially generate human efficacy data in H2 2024 U.S. FDA cleared IND for APR-1051, a highly...

Aprea Therapeutics, Inc. (NASDAQ:APRE) Director Bernd R. Seizinger Purchases 6,860 Shares

Aprea Therapeutics, Inc. (NASDAQ:APRE  Get Free Report) Director Bernd R. Seizinger acquired 6,860 shares of the firms stock in a transaction on Wednesday, March 13th. The stock was...

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.

Aprea Therapeutics Inc

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$1.48
Prev Close	$1.46
Open	$1.51
Dividend Yield	0.00%
50-Day Moving Average	$1.61
Beta	-2.21
Avg. Volume	38,229.00
PE Ratio	-0.63

52-Week High	$5.01
52-Week Low	$1.37
Market Capitalization	$8.5M
EPS (Annual)	-$2.35
Price to Book	0.63
Revenue Per Employee	$187,822.63
Enterprise Value/EBITDA	N/A

APRE
Aprea Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest APRE News

APRE Aprea Therapeutics Inc